Literature DB >> 8747138

Network analysis of PET-mapped visual pathways in Alzheimer type dementia.

B Horwitz1, A R McIntosh, J V Haxby, M Furey, J A Salerno, M B Schapiro, S I Rapoport, C L Grady.   

Abstract

Using path analysis to determine the systems-level neural networks mediating specific tasks from regional cerebral blood flow (rCBF) data obtained by positron emission tomography (PET), we recently found in young subjects strong functional linkages during a face matching task along a right hemisphere ventral network including occipital, temporal, and frontal regions. In this study, PET data obtained during a face matching task from mildly affected patients with dementia of the Alzheimer type (DAT) and healthy matched controls showed that (1) the neural model obtained in young subjects provides a good fit to data from old subjects; (2) although the DAT patients could perform this task with the same accuracy as controls, they did not use the same functional network.

Entities:  

Mesh:

Year:  1995        PMID: 8747138     DOI: 10.1097/00001756-199511270-00005

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  30 in total

1.  Functional MR imaging using a visually guided saccade paradigm for comparing activation patterns in patients with probable Alzheimer's disease and in cognitively able elderly volunteers.

Authors:  K R Thulborn; C Martin; J T Voyvodic
Journal:  AJNR Am J Neuroradiol       Date:  2000-03       Impact factor: 3.825

Review 2.  Functional brain mapping of psychopathology.

Authors:  G D Honey; P C Fletcher; E T Bullmore
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

3.  fMRI investigation of unexpected somatosensory feedback perturbation during speech.

Authors:  Elisa Golfinopoulos; Jason A Tourville; Jason W Bohland; Satrajit S Ghosh; Alfonso Nieto-Castanon; Frank H Guenther
Journal:  Neuroimage       Date:  2010-12-30       Impact factor: 6.556

4.  Spatial patterns of intrinsic brain activity in mild cognitive impairment and Alzheimer's disease: a resting-state functional MRI study.

Authors:  Zhiqun Wang; Chaogan Yan; Cheng Zhao; Zhigang Qi; Weidong Zhou; Jie Lu; Yong He; Kuncheng Li
Journal:  Hum Brain Mapp       Date:  2010-11-12       Impact factor: 5.038

5.  Investigating the neural basis for functional and effective connectivity. Application to fMRI.

Authors:  Barry Horwitz; Brent Warner; Julie Fitzer; M-A Tagamets; Fatima T Husain; Theresa W Long
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-05-29       Impact factor: 6.237

6.  Testing effective connectivity changes with structural equation modeling: what does a bad model tell us?

Authors:  Andrea B Protzner; Anthony R McIntosh
Journal:  Hum Brain Mapp       Date:  2006-12       Impact factor: 5.038

Review 7.  Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD.

Authors:  Lisa Mosconi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-04       Impact factor: 9.236

8.  Disrupted interactions among the hippocampal, dorsal attention, and central-executive networks in amnestic mild cognitive impairment.

Authors:  Ganesh B Chand; Ihab Hajjar; Deqiang Qiu
Journal:  Hum Brain Mapp       Date:  2018-09-11       Impact factor: 5.038

9.  Covariance PET patterns in early Alzheimer's disease and subjects with cognitive impairment but no dementia: utility in group discrimination and correlations with functional performance.

Authors:  Nikolaos Scarmeas; Christian G Habeck; Eric Zarahn; Karen E Anderson; Aileen Park; John Hilton; Gregory H Pelton; Matthias H Tabert; Lawrence S Honig; James R Moeller; Davangere P Devanand; Yaakov Stern
Journal:  Neuroimage       Date:  2004-09       Impact factor: 6.556

10.  Evidence from functional neuroimaging of a compensatory prefrontal network in Alzheimer's disease.

Authors:  Cheryl L Grady; Anthony R McIntosh; Sania Beig; Michelle L Keightley; Hana Burian; Sandra E Black
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.